phase ib/ii trial of combination pd-1 therapy against kidney cancer
Published 6 years ago • 33 plays • Length 4:55Download video MP4
Download video MP3
Similar videos
-
16:48
kidney cancer immunotherapy: pd-1 pathway clinical trials
-
4:10
combination of medi0680, an anti-pd-1 antibody, with durvalumab, an anti-pd-l1 antibody
-
3:48
the promise of pd1 inhibitors in kidney cancer
-
5:59
prosper rcc study of perioperative nivolumab for renal cell carcinoma - future trial
-
7:13
role of pd-l1 testing in kidney cancer
-
4:15
pd-l1 combination therapy clinical trials
-
5:29
first- and second-line treatments for locally advanced renal cell carcinoma
-
1:24
dr. mcdermott on the use of anti–pd-1 combinations in mrcc
-
9:02
pd1/ ctla4 : upfront or sequentially?
-
2:19
rini explores pd-1 inhibition in renal cell carcinoma
-
3:23
nivolumab improves overall survival for advanced kidney cancer
-
6:10
pd-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer
-
2:12
cabozantinib improves pfs in metastatic renal cell carcinoma
-
3:19
radvax: nivolumab / ipilimumab with sbrt for metastatic renal cell carcinoma
-
2:02
tki and checkpoint inhibitor combinations for kidney cancer: the immotion151 trial
-
3:59
checkmate 067 - combined nivolumab and ipilimumab
-
6:48
kidney cancer: treatment for stage 4 (metastatic)
-
6:24
asco 2013: nivolumab blocking pd1 in lung cancer and melanoma
-
2:43
cabozantinib after checkpoint inhibitors demonstrates preliminary efficacy in advanced rcc